Samuel Joseph Daniels - AstraZeneca | 人才画像

基本信息

浏览量：8

职业迁徙

个人简介

Experienced Researcher working with neo-epitope biomarkers of extracellular matrix components and their clinical application within fibrotic diseases, primarily hepatic diseases.

研究兴趣

论文共 28 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Design and Rationale for a Global Novel Non-Invasive Screening Observational Study Using Genetics and Non-Invasive Methodologies to Identify At-Risk MASLD Participants: the ALIGN Study

Samuel J. Daniels,Karin Nelander, John Eriksson,Lutz Jermutus, Jelena Saillard, Stephanie Oyesola,Federica Tavaglione,Marco Arrese, Alma Laura Ladron de Guevara,Umberto Vespasiani-Gentilucci,Naim Alkhouri,Jenny E. Blau

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2025)

引用0浏览0WOS引用

Safety, Tolerability, and Pharmacodynamics of AZD3366 (optimized Human CD39L3 Apyrase) Alone and in Combination with Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo‐Controlled Study

Dimitris Kardassis,Ann-Charlotte Egnell,Magnus Astrand,Samuel J. Daniels,Carl Whatling,Ola Fjellstrom,Anders Gabrielsen

Journal of the American Heart Associationno. 11 (2024)

引用0浏览0WOS引用

WED-270 Clinical Profile of Patients Considered At-Risk for MASH with Fibrosis Identified Through an Ongoing Global Screening Program with Genetics

Samuel Daniels,Karin Nelander, John Eriksson, Jelena Saillard,Lutz Jermutus,Federica Tavaglione, Joao-Filipe Raposo,Marco Arrese, Alma Laura Ladron de Guevara,Umberto Vespasiani Gentilucci,Naim Alkhouri,Jenny Blau

Journal of Hepatology (2024): S535-S536

引用0浏览0引用

Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Non-cirrhotic MASH with Fibrosis

Sudha S. Shankar,Samuel J. Daniels,Darren Robertson,Janeli Sarv,Jose Sanchez, Debra Carter,Lutz Jermutus,Benjamin Challis,Arun J. Sanyal

Clinical Gastroenterology and Hepatology (2024)

引用2浏览0WOS引用

Safety and Pharmacokinetics of AZD9550, a GLP-1R/GCGR Dual Agonist, in a First-in-Human Study

Petra Sulentic,Sarah Will,Samuel Daniels, Sivaneswary Genapathy,Jacqueline Naylor, April Barbour,Hongtao Yu, Simina Boca, Elin Carlsson, Sven Gopel,David Hornigold,Stephanie Oldham,Darren Robertson,Lutz Jermutus, Mahssa Karimi,Lars Hansen

OBESITY (2024): 161-162

引用0浏览0引用

PERFORMANCE OF NON-INVASIVE BIOMARKERS FOR THE DETECTION OF ADVANCED LIVER FIBROSIS IN BIOPSY CONFIRMED NASH PATIENTS ENROLLED IN PROXMO PHASE 2a

Samuel J. Daniels,Darren Robertson,Jose Sanchez,Janeli Sarv,Benjamin Challis,Arun J. Sanyal,Sudha S. Shankar

HEPATOLOGY（2022）

引用0浏览0引用

Changes in Hepatic Fat Fraction As Assessed by MRI-PDFF Are Correlated with Changes in Markers of Hepatic Inflammation, Disease Activity and Fibrosis in Biopsy-Proven Non-Cirrhotic NASH with Fibrosis

Samuel Daniels,Darren Robertson,Jose Sanchez,Janeli Sarv,Antonio Manzur,Lutz Jermutus,Arun Sanyal,Benjamin Challis,Sudha Shankar

JOURNAL OF HEPATOLOGY（2022）

引用0浏览0引用

Stage-dependent Expression of Fibrogenic Markers in Alcohol-Related Liver Disease

Mia Dahl Sorensen,Maja Thiele,Aleksander Krag,Samuel Joseph Daniels,Diana Julie Leeming,Morten Karsdal,Sonke Detlefsen

Pathology - Research and Practice（2022）

引用9浏览0WOS引用

Safety, Pharmacokinetics, and Pharmacodynamics of AZD3366 Alone and in Combination with Aspirin and Ticagrelor in Healthy Subjects

Dimitris Kardassis,Ann-Charlotte Egnell,Magnus Astrand,Samuel J. Daniels, Celeste Frickleton,Carl Whatling,Ola Fjellstrom,Anders Gabrielsen

CIRCULATION（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn